Evidence map›Paper›PMID 30867444›Full record

ArticleScientific reports2019

DNA damage signalling from the placenta to foetal blood as a potential mechanism for childhood leukaemia initiation.

Els Mansell, Nahid Zareian, Camille Malouf, Chrysa Kapeni, Natalie Brown, Christophe Badie, Duncan Baird, Jon Lane, Katrin Ottersbach, Allison Blair and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Els MansellSchool of Clinical Science, University of Bristol, Learning and Research Centre, Southmead Hospital, Bristol, UK. els.mansell@med.lu.se.
Nahid ZareianSchool of Clinical Science, University of Bristol, Learning and Research Centre, Southmead Hospital, Bristol, UK.
Camille MaloufMRC Centre for Regenerative Medicine, SCRM Building, The University of Edinburgh, Edinburgh Bioquarter 5 Little France Drive, Edinburgh, UK.
Chrysa KapeniMRC Centre for Regenerative Medicine, SCRM Building, The University of Edinburgh, Edinburgh Bioquarter 5 Little France Drive, Edinburgh, UK.
Natalie BrownCancer Mecanisms and Biomarkers, Department of Radiation Effects, Public Health England's Centre for Radiation, Chemical and Environmental Hazards (CRCE), Chilton, Didcot, Oxon, UK.
Christophe BadieCancer Mecanisms and Biomarkers, Department of Radiation Effects, Public Health England's Centre for Radiation, Chemical and Environmental Hazards (CRCE), Chilton, Didcot, Oxon, UK.ORCID 0000-0003-4572-5008
Duncan BairdDivision of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
Jon LaneSchool of Biochemistry, University of Bristol, Bristol, UK.ORCID 0000-0002-6828-5888
Katrin OttersbachMRC Centre for Regenerative Medicine, SCRM Building, The University of Edinburgh, Edinburgh Bioquarter 5 Little France Drive, Edinburgh, UK.
Allison BlairSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
C Patrick CaseSchool of Clinical Science, University of Bristol, Learning and Research Centre, Southmead Hospital, Bristol, UK.
MRC Centre for Regenerative Medicine · GBSouthmead Hospital · GBPublic Health England · GBUniversity of Bristol · GBCardiff University · GB

Funding

Cancer Research UK 23581Medical Research Council MR/K017047/1
6 · The paper itself

Abstract

For many diseases with a foetal origin, the cause for the disease initiation remains unknown. Common childhood acute leukaemia is thought to be caused by two hits, the first in utero and the second in childhood in response to infection. The mechanism for the initial DNA damaging event are unknown. Here we have used in vitro, ex vivo and in vivo models to show that a placental barrier will respond to agents that are suspected of initiating childhood leukaemia by releasing factors that cause DNA damage in cord blood and bone marrow cells, including stem cells. We show that DNA damage caused by in utero exposure can reappear postnatally after an immune challenge. Furthermore, both foetal and postnatal DNA damage are prevented by prenatal exposure of the placenta to a mitochondrially-targeted antioxidant. We conclude that the placenta might contribute to the first hit towards leukaemia initiation by bystander-like signalling to foetal haematopoietic cells.

Indexed as

DNA DamageSignal TransductionCarcinogensChromosome AberrationsCulture Media, ConditionedFemaleFibroblastsHumansInfant, NewbornLeukemia, Myeloid, AcutePlacentaPrecursor Cell Lymphoblastic Leukemia-LymphomaPregnancyStem CellsTrophoblastsCarcinogensCulture Media, Conditioned

Identifiers

PMID30867444
PMCPMC6416312
OpenAlexW2921628287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.